RBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended Mammograms

RBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended Mammograms

October 20, 2022 Eric Jones 0

RBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended MammogramsRBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended MammogramsRBMA Executive Director Bob Still decries Medicare cuts that would ‘damage the health of the American people’

RBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended Mammograms
RPAN Logo

RPAN Logo

WASHINGTON – October 20, 2022 – (Newswire.com)

A new study of current or eligible Medicare recipients conducted on behalf of the Radiology Patient Action Network shows that nearly half of women indicate that they have not received a mammogram in the last three years. Conducting and released during Breast Cancer Awareness Month, the study also found that 80 percent of Americans are concerned with proposed cuts to Medicare, and 90 percent of Americans view maintaining Medicare coverage as important.

“As policymakers continue to propose cuts to Medicare, it is clear any new cuts would worsen health inequities and damage the health of the American people,” said Bob Still, Executive Director of the RBMA. “At a time when patients are already having difficulty receiving the care they need — like mammography screenings proven to detect and prevent breast cancer — members of Congress should take note of these findings and protect Medicare.”

Dr. Kellie Schenk, a board-certified diagnostic radiologist with EPIC Imaging, PC, in Oregon and Imaging for a Cause participant, underscored the severity of the survey’s mammography findings. “Breast cancer is the most commonly diagnosed cancer among women and, if not caught and treated early, can be disfiguring and deadly. We recommend average-risk women receive mammography screenings every year beginning at age 40 and high-risk women talk to their doctor about screenings prior to 40 to increase the chances of early detection, which not only saves lives but makes treatment much easier and less disruptive for patients and their families. It is alarming that nearly half of Medicare-aged women haven’t received their annual mammogram given the benefits of screening in this age group, and we encourage them to get one scheduled as soon as possible. It is clear that further cuts to Medicare providers and vital screening services would only exacerbate this issue by limiting appointments and compromising quality of care.”

In addition to survey respondents’ concern for Medicare cuts and lack of mammography screenings, 1 in 4 current patients reported having difficulty scheduling doctors’ appointments due to delays or rescheduling. Almost half of all respondents said they would be less likely to support a member of Congress if they advocate for cuts.

The survey was conducted Sept. 25 through Sept. 27, 2022. The national survey sample consists of 1,632 Americans either enrolled in Medicare or Medicare-eligible. Margin of Error is +/-2.5% with a 95% level of confidence. The study was jointly sponsored by the Medical Imaging and Technology Alliance (MITA), Imaging for a Cause, and the Radiology Business Management Association (RBMA) and conducted by the Remington Research Group.

About Imaging for a Cause

Imaging for a Cause Foundation (ICF) is a 501(c)(3) nonprofit foundation that coordinates communication between imaging centers and Federally Qualified Community Health Centers. It has a decade-long history of fostering charitable care for thousands of patients, from Virginia to Minnesota to Washington State.

About MITA

The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment manufacturers, innovators, and product developers. It represents companies whose sales comprise more than 90 percent of the global market for advanced medical imaging technology. For more information, visit www.medicalimaging.org

About RBMA

The Radiology Business Management Association (RBMA) is an industry-leading organization comprised of more than 2,100 professionals who focus on the business of radiology. RBMA members support diagnostic imaging, interventional radiology and radiation oncology providers in the full spectrum of practice settings. RBMA connects members nationwide to valuable information, education, and practice-related resources and serves as an authoritative industry voice on behalf of shared member interests.

Contact Information:

Will Sweet

RBMA
[email protected]

Press Release Service
by
Newswire.com

Original Source:

RBMA’s Radiology Patient Action Network Study Shows Nearly Half of Women Not Receiving Recommended Mammograms

One of America’s Largest Employers of Psychiatrists, Talkiatry, Partners With Cedar to Enhance Patients’ Financial Experience

One of America’s Largest Employers of Psychiatrists, Talkiatry, Partners With Cedar to Enhance Patients’ Financial Experience

October 20, 2022 Eric Jones 0

One of America’s Largest Employers of Psychiatrists, Talkiatry, Partners With Cedar to Enhance Patients’ Financial ExperienceOne of America’s Largest Employers of Psychiatrists, Talkiatry, Partners With Cedar to Enhance Patients’ Financial ExperienceTalkiatry’s implementation of Cedar Pay brings a consumer-focused payment experience to a national patient base

NEW YORK – October 20, 2022 – (Newswire.com)

Talkiatry, a leading provider of high-quality, in-network psychiatric care and one of the largest employers of psychiatrists in the United States, announced today that it has partnered with Cedar, an enterprise healthcare engagement platform that improves the end-to-end consumer financial journey, to enhance the online billing experience for its rapidly expanding patient base. 

Launched in 2020, Talkiatry is increasing the accessibility and affordability of high-quality psychiatric care. In network with over 60 major insurance plans, Talkiatry also conducts virtual visits that make it easy for patients to be seen. Talkiatry’s practice employs hundreds of psychiatrists from diverse backgrounds across a range of specialties—from child and adolescent to adult to geriatric—and uses proprietary technology to personalize care and improve outcomes in previously unachievable ways. 

“In psychiatry, billing has long been a challenge for patients,” said Robert Krayn, Talkiatry’s co-founder and CEO. “It’s opaque and complex, and 45% of psychiatrists don’t even accept insurance. We’re changing that. We want our patients to focus on their health, not on trying to decipher confusing statements, and Cedar is an important part of how we use technology to improve the patient experience.”

Cedar Pay, Cedar’s post-visit patient engagement and payment platform, delivers a more streamlined patient financial journey and eases the consumer burden of paying for healthcare. Through Cedar Pay, Talkiatry will be able to empower their national patient base to better manage their healthcare bills through consumer-friendly statements, optimized outreach and flexible payment options. 

“It is often difficult for Americans to access mental health treatment, due to factors like cost of care and lack of in-network providers,” said Florian Otto, Cedar’s co-founder and CEO. “At Cedar, our mission is simple: empower people to easily and affordably pursue the care they need, and we are looking forward to partnering with our first psychiatry provider, Talkiatry, as they enhance their digital strategy to meet patients where they are. And, with a simplified payments experience, their psychiatry providers will be able to focus on providing the best quality care.” 

Cedar Pay is now live and available for Talkiatry’s patients. 

About Talkiatry
Talkiatry is a national mental health practice that provides in-network psychiatry and therapy. They were co-founded by a patient and a triple-board-certified psychiatrist to solve the problems both groups face in accessing and providing the highest quality mental healthcare. 60% of adults in the U.S. with a diagnosable mental illness go untreated every year because care is inaccessible, while 45% of clinicians are out of network with insurers because reimbursement rates are low and paperwork is unduly burdensome. With innovative technology and a human-centered philosophy, Talkiatry provides patients with the care they need—and allows psychiatrists to focus on why they got into medicine. Learn more at www.talkiatry.com and follow us on InstagramFacebook, and LinkedIn.

About Cedar
Cedar is committed to improving the healthcare billing experience for all. With an innovative platform that connects providers and payers, Cedar empowers healthcare consumers with a personalized journey—all powered by data science and interactive design. For Cedar clients, this leads to increased payments, more efficient operations and greater consumer loyalty. To learn more about why leading U.S. healthcare organizations trust Cedar to manage the end-to-end payments experience from pre-registration to post-visit billing, visit www.cedar.com and join us on LinkedInTwitterFacebook and YouTube.

Contact Information:

Jenny Fiegoli

Cedar
[email protected]

Hirsch Leatherwood

Talkiatry
[email protected]

Press Release Service
by
Newswire.com

Original Source:

One of America’s Largest Employers of Psychiatrists, Talkiatry, Partners With Cedar to Enhance Patients’ Financial Experience

Scitech and the Plough Center Announce Manufacturing Agreement

Scitech and the Plough Center Announce Manufacturing Agreement

October 20, 2022 Eric Jones 0

Scitech and the Plough Center Announce Manufacturing AgreementScitech and the Plough Center Announce Manufacturing AgreementThe Contract Manufacturing Agreement Will Provide the Clinical Supply of ST-001, SciTech’s Lead Drug Candidate for Cancer

GROSSE POINTE FARMS, Mich. – October 20, 2022 – (Newswire.com)

SciTech Development is pleased to announce that it has signed a $600K manufacturing agreement with The Plough Center for Sterile Drug Delivery Systems. The Plough Center will deliver the clinical supply of SciTech’s lead cancer drug candidate, ST-001 nanoFenretinide. Delivery of the drug is expected in Q4 2022, which will be immediately followed by SciTech’s first human clinical trial using ST-001 for Lymphoma. (ClinicalTrials.gov Identifier: NCT04234048). 

Earle Holsapple, President of SciTech Development, said, “SciTech chose The Plough Center for their expertise in drug delivery manufacturing in addition to their intimate knowledge of combining and processing nanoparticles. We are confident that SciTech has selected the best possible partner and that this relationship will continue as we move forward, not only with ST-001, along with other drugs in our pipeline. This is a major milestone for SciTech as we rapidly approach our human clinical trials.” 

“We are excited to serve as the contract manufacturer for ST-001. We are extremely eager to work with SciTech in its mission to cure several cancer types,” said Dr. Harry Kochat, Director of Operations and Business Development of The Plough Center. “ST-001 nanoFenretinide combines the SciTech Delivery Platform (SDP) and the promising drug fenretinide as a broadly applicable cancer therapeutic. The Plough Center will utilize our comprehensive NanoSpace formulation platform to provide ST-001 for clinical trials. Our in-house NanoSpace platform can produce nanosuspensions, nanoemulsions, and liposomal encapsulation products.” The Plough Center specializes in developing and manufacturing complex, early-stage investigational drugs. 

About SciTech Development 

SciTech Development LLC is a clinical-stage pharmaceutical company that has developed a patented, nanoparticle drug delivery platform (SDP) that maximizes the bioavailability of water-insoluble therapeutics. SciTech’s lead drug candidate ST-001 nanoFenretinide combines SDP and the drug fenretinide as a broadly applicable anticancer drug. ST-001 has an FDA Investigational New Drug (IND) approval, is Orphan Drug designated, and is Phase 1 clinical trial ready. More information about SciTech can be found at www.SciTechSDP.com

About The Plough Center 

The mission of The Plough Center for Sterile Drug Delivery Solutions is to help patients by expediting efforts to bring innovative, life-saving medicines to market. The Plough Center is a US-FDA registered cGMP sterile drug manufacturing facility owned by the University of Tennessee Health Science Center in Memphis. Plough assists universities, scientific communities, and the pharmaceutical industry in the manufacture and delivery of therapeutic advances that will improve patient standard of care. More information about The Plough Center can be found at https://www.uthsc.edu/plough-center/.

Contact Information:

Harry Kochat, PhD. 

Director of Operations & Business Development 
[email protected]

David Schaffer

Director Investor Relations
[email protected]

Press Release Service
by
Newswire.com

Original Source:

Scitech and the Plough Center Announce Manufacturing Agreement

Toetal Solutions Secures ,800,000 in New Financing to Pursue Product Development and Regulatory Approval

Toetal Solutions Secures $1,800,000 in New Financing to Pursue Product Development and Regulatory Approval

October 20, 2022 Editor 0

Toetal Solutions Secures ,800,000 in New Financing to Pursue Product Development and Regulatory ApprovalToetal Solutions Secures ,800,000 in New Financing to Pursue Product Development and Regulatory Approval

MALVERN, Pa. – October 20, 2022 – (Newswire.com)

Toetal Solutions, Inc., a foot and ankle medical device company, announced it had closed $1,800,000 in additional financing from Runway Healthcare, LP, with participation from Runway Healthcare investors. Toetal Solutions plans to use the proceeds to finalize product development and obtain regulatory clearance for its flagship product, the Ziptoe™ Hammertoe System.

The Ziptoe Hammertoe System enables foot and ankle surgeons to address rigid hammertoe deformities with a simple, easy-to-use implant. “The system has been thoughtfully designed with surgeon input to address the common pitfalls of the devices available to surgeons today. The Ziptoe implant is easy to use and provides an incredibly stable fusion from the moment it is deployed. Additionally, it enables surgeons to address the MTPJ if necessary, addressing the Toetal Pathology with a Toetal Solution,” stated Nick Romansky, DPM. The Ziptoe system includes a proprietary deployable nitinol implant that comes sterile packed with all necessary disposable instrumentation to perform the procedure in any surgical setting efficiently and effectively. 

“This financing should enable our team to finalize the development of the Ziptoe Hammertoe System and achieve FDA approval, fundamentally changing how surgeons address forefoot deformities. We aim to improve patient outcomes while making the surgeons’ lives easier,” said Co-Founder and Chief Technology Officer William Rhoda. 

Toetal Solutions is Runway Healthcare’s second portfolio company. The medical device accelerator combines capital and direct management to bring commercially ready opportunities to the medical device industry following regulatory approval. Runway Healthcare will seek to transition Toetal Solutions’ ownership to a larger multi-national healthcare company for commercialization.

About Toetal Solutions, Inc.:

Toetal Solutions was founded in 2021 to create easy-to-use and clinically effective solutions for foot and ankle deformities. The Ziptoe™ Hammertoe System features a sterile packed procedure kit and implant to address ridged hammertoe deformity. 

About Runway Healthcare, LP:

Runway Healthcare is an early-stage MedTech Accelerator focused on early-stage technology in the Orthopedic, Cardiovascular, and Neurology sectors. Runway finances and manages the product development process of its portfolio companies. Upon navigating a portfolio company through the regulatory process, Runway Healthcare will seek to transition its portfolio companies’ ownership to larger multi-national healthcare companies for commercialization.

Forward-Looking Statements:

This press release contains “forward-looking statements” concerning the development of Toetal Solutions products, the potential benefits and attributes of those products, and the company’s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions, and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Toetal Solutions undertakes no obligation to update any forward-looking statements for any reason.

Inquiries: [email protected]

Contact Information:

Jeff O’Donnell, Jr

President and CEO

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Toetal Solutions Secures $1,800,000 in New Financing to Pursue Product Development and Regulatory Approval

As Flu Cases Climb Early, Hospitals Gearing Up With US Med-Equip

As Flu Cases Climb Early, Hospitals Gearing Up With US Med-Equip

October 20, 2022 Editor 0

As Flu Cases Climb Early, Hospitals Gearing Up With US Med-EquipAs Flu Cases Climb Early, Hospitals Gearing Up With US Med-EquipHealthcare providers turning to USME, leading provider of rented medical equipment and patient beds and therapeutic surfaces, to prepare for patient surges

As Flu Cases Climb Early, Hospitals Gearing Up With US Med-Equip
CDC: Flu Cases Increasing Early

CDC’s FluView report shows early increases in the proportion of respiratory specimens testing positive for flu

HOUSTON – October 20, 2022 – (Newswire.com)

With the CDC reporting flu cases starting to climb, healthcare providers across the U.S. are preparing for an early wave of influenza this winter. In addition to urging everyone eligible to get immunized against COVID-19 and the flu, hospitals are renting medical equipment from US Med-Equip (USME) to help treat any influx of patients expected this flu season. 

The cases of respiratory illnesses caused by the flu typically start to climb exponentially in November, spike through the holiday months and peak through the end of February. The Centers for Disease Control and Prevention this week reported “early increases in seasonal influenza activity … in most of the United States.”

Amid prolonged strain on clinical staff and budgets since COVID struck, hospitals are turning to trusted partner USME—the nation’s leading provider of rented respiratory, neonatal, infusion and other devices—to bolster their supplies of life-saving equipment before the annual flu epidemic strikes. The Houston-based company partners with top hospitals across the nation in the rental, sales, service and asset management of movable medical equipment ranging from ventilators to patient beds and therapeutic surfaces that a hospital may need based on the number of patients expected or admitted at the time. 

“We’re all hoping for a mild season with low case numbers and as few hospitalizations as possible, but healthcare providers are not waiting for flu cases to spike before securing and servicing equipment to be ready to help any surge of patients,” US Med-Equip CEO Greg Salario said. 

Contact Information:

Matthew Stanford

Communications Specialist

[email protected]

713-983-8860

Press Release Service
by
Newswire.com

Original Source:

As Flu Cases Climb Early, Hospitals Gearing Up With US Med-Equip

Million Covid cases feared in North Korea – BBC News

Million Covid cases feared in North Korea – BBC News

October 20, 2022 Eric Jones 0

Million Covid cases feared in North Korea – BBC NewsMillion Covid cases feared in North Korea – BBC NewsNorth Korea’s leader Kim Jong-un has criticised health officials and ordered the army to help distribute medicine, as a wave of Covid cases sweeps through the country. More than a million people have now been sickened by what Pyongyang is calling a “fever”, state media said. Some 50 people have died, but it’s unclear how […]

The Power of Immersive Sound Therapy for the Childbirth Journey Comes to the Happy Mama Expo

The Power of Immersive Sound Therapy for the Childbirth Journey Comes to the Happy Mama Expo

October 19, 2022 Editor 0

The Power of Immersive Sound Therapy for the Childbirth Journey Comes to the Happy Mama ExpoThe Power of Immersive Sound Therapy for the Childbirth Journey Comes to the Happy Mama Expo

The Power of Immersive Sound Therapy for the Childbirth Journey Comes to the Happy Mama Expo
Walter Werzowa at Happy Mama Expo

Headlining Reach’s Happy Mama Expo will be Walter Werzowa, award-winning Austrian composer and CEO of HealthTunes, on Saturday, Oct. 22

SAN DIEGO – October 19, 2022 – (Newswire.com)

The Happy Mama Expo is focused on Reach Healthcare’s comprehensive Happy Mama platform and app designed to improve the delivery and wellness of maternal health, from end to end. This platform was designed for and with pregnant women. It provides physical, mental, emotional, spiritual, social, and economic support for those planning, expecting, and starting new families. Happy Mama guides and enables women to customize their experiences ranging from pre-conception, pregnancy, labor, and delivery to 12 months postpartum. In recognition of its leading-edge innovations, Happy Mama was the winner of a 2022 International CES Innovations Award.

Registration for the virtual Happy Mama Expo is open and admission is free. Get your ticket today. More info at http://happymama.global

Headlining Reach’s Happy Mama Expo will be Walter Werzowa, award-winning Austrian composer and CEO of HealthTunes, on Saturday, Oct. 22. “Music brings us together. It touches and moves us and creates a bond between you and your baby,” describes Werzowa. At the Happy Mama Expo, Werzowa will demonstrate the art of music and guided meditations on the mother’s well-being and health.

Werzowa is famous for corporate jingles, including mnemonics for Intel (the most performed audio branding mnemonic and melody in broadcast history), Samsung, T-Mobile, Humana, UC Health, Pantene, TBS, Fox Sports, and many more. Werzowa is also acclaimed for his artificial intelligence (AI)-enabled completion of Beethoven’s unfinished Tenth Symphony. 

Additional announcements about collaborations between Happy Mama and HealthTunes will be made on Oct. 22.

MATERNAL CHALLENGES

U.S. maternal morbidity and mortality rates have worsened over the last few decades and too many women suffer PTSD related to traumatic birth incidents. 

Reach’s Happy Mama innovative platform was designed for and with pregnant women to improve the delivery of maternal health, from end-to-end. While today’s pregnancy, labor and delivery, and postpartum care are focused primarily on the physical aspects, it often neglects the woman’s emotional and psychological needs during the pregnancy journey. 

Clinical studies indicate that music and sound offer positive physiological benefits as a digital therapeutic modality during childbirth and the postpartum journey. It has been shown to reduce pain and anxiety, enhance a woman’s self-confidence and sense of control, as well as improve her postpartum well-being.

In 2021, The Journal of Music Theory featured an article entitled The Effects of Music on Pain: A Meta-Analysis. This is one of several studies illustrating the positive benefits of sound and music on maternal-infant health. This report cited decreased pain, emotional distress, heart rate, blood pressure, and respiration rate as well as decreased use of anesthesia and pain medication. Other studies indicate reduced premature births, cesareans, and postpartum depression. 

“There is a growing opportunity for healthcare providers to create better labor and delivery experiences, and for pregnant women to feel safe and have a true sense of control during childbirth,” points out Fran Ayalasomayajula, Reach’s CEO. The Happy Mama mission aligns with the White House Blueprint for Addressing the Maternal Health Crisis and the Centers for Medicare & Medicaid Services (CMS)’s “Birthing-Friendly” hospital designation.

Happy Mama offers a seamless end-to-end journey, starting with its consumer therapy app for home use; Happy Mama’s maternal health program for hospitals and birth centers for labor and delivery; and then returning home for the postnatal/postpartum journey.

OTHER COLLABORATIONS

The HealthTunes collaboration joins others within the Reach and Happy Mama orbit. At its 2021 Happy Mama launch, Reach announced its partnership with Harman International, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. that is focused on connected technologies for automotive, consumer, and enterprise markets. Happy Mama works with Harman’s Digital Transformation Solutions (DTS) and Harman Audio which includes Harman Kardon, JBL, AKG, and many others.

MORE ABOUT THE HAPPY MAMA EXPO

The Happy Mama Expo is Saturday, Oct. 22, from 7 a.m.-7 p.m. EDT. 

It’s the biggest virtual maternity fair of 2022. It is a free, general public event. The purpose of the event is for expecting and new moms and their care teams to find solutions to their needs along the journey to motherhood and to help prevent avoidable pregnancy-related complications. The program is holistic and touches on a variety of topics, including maternal mental health and well-being, heart health, nutrition, and career management. This event also offers live entertainment, trivia, digital swag bags, cool prizes, and more.

Happy Mama Links:

Happy Mama Expo Tickets: https://happymama.global/expo2022

Happy Mama Website: https://happymama.global

Happy Mama Disaster Relief Program: https://happymama.global/disaster-relief-program

#happymama

EXPERIENCE HAPPY MAMA LIVE AT THESE AND MANY MORE EVENTS:

Oct. 28-30, 2022       DONA International Summit 2022, Online

Nov. 13-16, 2022      HLTH 2022, Las Vegas, NV

Jan. 4-7, 2023        HARMAN Explore 2023, Las Vegas

Jan. 5-8, 2023           CES 2023, Las Vegas, NV

Feb. 6-11, 2023         Society for Maternal-Fetal Medicine (SMFM) Annual Meeting, San Francisco, CA

March 26-29, 2023       ViVE 2023, Nashville, TN

April 17-21, 2023       HIMSS23, Chicago, IL

May 5-10, 2023           American College of Nurse-Midwives (ACNM) Annual Meeting, Orlando, FL 

See the full calendar of events: https://happymama.global/live

ABOUT REACH

REACH is a 501c3 global innovative social impact organization whose mission is to improve and transform healthcare delivery and outcomes for providers and patients, as well as to offer cost-effective solutions for payers. 

Maternal mortality and morbidity prevention is a top priority area for the organization. Reach is the founder of the National Save Moms Campaign (http://savemoms.us), Save Moms Global (http://savemoms.global), Maternal Application of Technology for Community Health (MATCH) Coalition (http://matchcoalition.us), and Happy Mama (http://happymama.global)

Reach, established in 2016,  is focused on pragmatically improving large-scale and sustainable health programs for enhanced healthcare equity, access, and delivery based on its four pillars: (1) Research to identify where change is needed that could result in actionable outcomes; (2) Education; (3) Thought Leadership and (4) Innovative Immersive Special Interest Therapeutic Platforms, including Happy Mama, focused on maternal health for mothers as well as clinicians; Workforce Wellness to tackle clinician burnout; and IB Healthy Wellness and Remote Care digital therapeutics for rehab, chronic disease management, healthy aging, and more.

Reach welcomes new partnerships, sponsorships, and grassroots affiliates as it works to drive massive impact for better and more equitable health care outcomes.

Contact Information:

Matt Walker

Community Outreach Lead

[email protected]

619-800-6443

Press Release Service
by
Newswire.com

Original Source:

The Power of Immersive Sound Therapy for the Childbirth Journey Comes to the Happy Mama Expo